Literature DB >> 11167898

Migraine with aura and reproductive life events: a case control study.

F Granella1, G Sances, E Pucci, R E Nappi, N Ghiotto, G Napp.   

Abstract

The course of migraine without aura (MO) is greatly influenced by the events of female reproductive life. Much less is known about migraine with aura (MA). The aim of this study was to evaluate the relationship between MA and the milestones of reproductive life. A retrospective case control study was carried out on 100 women affected by migraine with typical aura (cases) and 200 age-matched women with MO (controls). Premenstrual syndrome was found to be much more common among the patients with MA (odds ratio (OR) 6.0; confidence interval (CI) 3.1-11.6). Menstrually triggered migraine was more frequently encountered among MO than among MA patients (MA 15.0%; MO 53.5%; OR 0.1; CI 0.1-0.3). In both forms of migraine, pregnancy had a favourable effect; however, a lower percentage of MA (43.6%) than MO patients (76.8%; OR 0.2; CI 0.1-0.5) showed improvement or remission. The use of oral contraceptives worsened migraine in MA more frequently than in MO patients (MA 56.4%; MO 25.3%; OR 3.8; CI 1.6-9.3). The course of MA seems to be influenced by female reproductive life events, but in a different way with respect to MO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11167898     DOI: 10.1111/j.1468-2982.2000.00112.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  49 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study.

Authors:  Ihunnaya O Frederick; Chunfang Qiu; Daniel A Enquobahrie; Sheena K Aurora; B Lee Peterlin; Bizu Gelaye; Michelle A Williams
Journal:  Headache       Date:  2013-08-28       Impact factor: 5.887

Review 3.  Migraine during pregnancy: options for therapy.

Authors:  Anthony W Fox; Merle L Diamond; Egilius L H Spierings
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors:  Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal:  Curr Pain Headache Rep       Date:  2012-10

5.  Acute headache diagnosis in pregnant women: a hospital-based study.

Authors:  Matthew S Robbins; Constantine Farmakidis; Ashlesha K Dayal; Richard B Lipton
Journal:  Neurology       Date:  2015-08-19       Impact factor: 9.910

Review 6.  Migraine in pregnancy and lactation.

Authors:  Paru S David; Juliana M Kling; Amaal J Starling
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 7.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 8.  Genetics of menstrual migraine: the epidemiological evidence.

Authors:  Michael Bjørn Russell
Journal:  Curr Pain Headache Rep       Date:  2010-10

9.  Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Authors:  Vincent T Martin; Jeanne Ballard; Michael P Diamond; Lisa K Mannix; Frederick J Derosier; Shelly E Lener; Alok Krishen; Susan A McDonald
Journal:  J Womens Health (Larchmt)       Date:  2014-02-28       Impact factor: 2.681

Review 10.  Menstrual migraine: a review of prophylactic therapies.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.